Back
Sarepta Therapeutics, Inc.
SRPT
$19.89
-3.75%
Overview
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on helping patients through the discovery and development of ribonucleic acid (RNA)-targeted therapeutics,...
Open
$0.00
Prior close
$20.67
Today's high
$0.00
Today's low
$0.00
52 Week high
$25.32
52 Week low
$14.68
News
MarketBeat • 4 days ago • SRPT
Sarepta Sees ELEVIDYS Demand Stabilizing as FSHD, DM1 Readouts Near
Seeking Alpha • 4 days ago • SRPT
Sarepta Therapeutics, Inc. (SRPT) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Benzinga • 10 days ago • SRPT
A Rivals Clinical Stumble Sends Sarepta Therapeutics Stock Lower
Reuters • 10 days ago • SRPT
Dyne, Sarepta shares tumble as Novartis setback weighs on muscle disease drug developers
Business Wire • 10 days ago • SRPT
Sarepta Therapeutics Announces Recipients of Route 79, The Duchenne Scholarship Program, for the 2026-2027 Academic Year
